164 related articles for article (PubMed ID: 38563112)
1. HPV DNA Testing and Mobile Colposcopy for Cervical Precancer Screening in HIV Positive Women: A Comparison Between Two Settings in Ghana and Recommendation for Screening.
Effah K; Anthony R; Tekpor E; Amuah JE; Wormenor CM; Tay G; Kraa SEY; Katso AM; Akonnor CA; Kemawor S; Danyo S; Atuguba BH; Essel NOM; Akakpo PK
Cancer Control; 2024; 31():10732748241244678. PubMed ID: 38563112
[TBL] [Abstract][Full Text] [Related]
2. [Real-world research on cervical cancer screening program and effect evaluation for Chinese population].
Zhao YQ; Dai Y; Dang L; Kong LH; Zhang Y; Feng RM; Qiao YL; Lang JH
Zhonghua Zhong Liu Za Zhi; 2018 Oct; 40(10):764-771. PubMed ID: 30392341
[No Abstract] [Full Text] [Related]
3. Triage of HPV positivity in a high HIV prevalence setting: A prospective cohort study comparing visual triage methods and HPV genotype restriction in Botswana.
Luckett R; Ramogola-Masire D; Gompers A; Moraka N; Moyo S; Sedabadi L; Tawe L; Kashamba T; Gaborone K; Mathoma A; Noubary F; Kula M; Grover S; Dreyer G; Botha MH; Makhema J; Shapiro R; Hacker MR
Int J Gynaecol Obstet; 2024 May; 165(2):507-518. PubMed ID: 37950533
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of portable colposcopy and human papillomavirus testing for screening of cervical cancer in rural China.
Newman H; Hu J; Li X; He J; Bradford L; Shan S; Wu X; Zhu B; Yang W; Fu B; Zhu B; Gao G
Int J Gynecol Cancer; 2019 Jan; 29(1):23-27. PubMed ID: 30640679
[TBL] [Abstract][Full Text] [Related]
5. Prospective cohort study examining cervical cancer screening methods in HIV-positive and HIV-negative Cambodian Women: a comparison of human papilloma virus testing, visualization with acetic acid and digital colposcopy.
Thay S; Goldstein A; Goldstein LS; Govind V; Lim K; Seang C
BMJ Open; 2019 Feb; 9(2):e026887. PubMed ID: 30804036
[TBL] [Abstract][Full Text] [Related]
6. High Prevalence of Cervical High-Grade Lesions and High-Risk Human Papillomavirus Infections in Women Living with HIV: A Case for Prioritizing Cervical Screening in This Vulnerable Group.
Gupta R; Hussain S; Hariprasad R; Dhanasekaran K; Verma S; Agarwal V; Sandeep ; Parveen S; Kaur A; Verma CP; Amita ; Dwivedi R; Singh S; Gupta S
Acta Cytol; 2022; 66(6):496-506. PubMed ID: 35760059
[TBL] [Abstract][Full Text] [Related]
7. Tritesting in Battor, Ghana: an integrated cervical precancer screening strategy to mitigate the challenges of multiple screening visits and loss to follow-up.
Effah K; Tekpor E; Wormenor CM; Essel NOM; Kemawor S; Sesenu E; Danyo S; Kitcher YT; Klutsey GB; Tay G; Tibu F; Abankroh KA; Atuguba BH; Akakpo PK
Ecancermedicalscience; 2023; 17():1645. PubMed ID: 38414966
[TBL] [Abstract][Full Text] [Related]
8. The clinical effectiveness and cost-effectiveness of primary human papillomavirus cervical screening in England: extended follow-up of the ARTISTIC randomised trial cohort through three screening rounds.
C Kitchener H; Canfell K; Gilham C; Sargent A; Roberts C; Desai M; Peto J
Health Technol Assess; 2014 Apr; 18(23):1-196. PubMed ID: 24762804
[TBL] [Abstract][Full Text] [Related]
9. Screening of cervical neoplasia in HIV-infected women in India.
Joshi S; Sankaranarayanan R; Muwonge R; Kulkarni V; Somanathan T; Divate U
AIDS; 2013 Feb; 27(4):607-15. PubMed ID: 23079814
[TBL] [Abstract][Full Text] [Related]
10. Diagnostic accuracy of cervical cancer screening and screening-triage strategies among women living with HIV-1 in Burkina Faso and South Africa: A cohort study.
Kelly HA; Chikandiwa A; Sawadogo B; Gilham C; Michelow P; Lompo OG; Omar T; Zan S; Magooa P; Segondy M; Nagot N; Meda N; Delany-Moretlwe S; Mayaud P;
PLoS Med; 2021 Mar; 18(3):e1003528. PubMed ID: 33661957
[TBL] [Abstract][Full Text] [Related]
11. A pilot study of HPV DNA and cytology testing in 50,159 women in the routine Mexican Social Security Program.
Lazcano-Ponce E; Lörincz AT; Salmerón J; Fernández I; Cruz A; Hernández P; Mejia I; Hernández-Avila M
Cancer Causes Control; 2010 Oct; 21(10):1693-700. PubMed ID: 20617376
[TBL] [Abstract][Full Text] [Related]
12. Upscaling cervical cancer screening and treatment for women living with HIV at a rural referral hospital in Tanzania: protocol of a before-and-after study exploring HPV testing and novel diagnostics.
Di Salvo I; Mnzava D; Nicoletti GJ; Senkoro E; Ndege RC; Huang DJ; Makunja NT; Kassiga GI; Kaufmann AM; Weisser M; Kind AB
BMC Health Serv Res; 2023 Mar; 23(1):234. PubMed ID: 36894985
[TBL] [Abstract][Full Text] [Related]
13. Performance of standardised colposcopy to detect cervical precancer and cancer for triage of women testing positive for human papillomavirus: results from the ESTAMPA multicentric screening study.
Valls J; Baena A; Venegas G; Celis M; González M; Sosa C; Santin JL; Ortega M; Soilán A; Turcios E; Figueroa J; Rodríguez de la Peña M; Figueredo A; Beracochea AV; Pérez N; Martínez-Better J; Lora O; Jiménez JY; Giménez D; Fleider L; Salgado Y; Martínez S; Bellido-Fuentes Y; Flores B; Tatti S; Villagra V; Cruz-Valdez A; Terán C; Sánchez GI; Rodríguez G; Picconi MA; Ferrera A; Mendoza L; Calderón A; Murillo R; Wiesner C; Broutet N; Luciani S; Pérez C; Darragh TM; Jerónimo J; Herrero R; Almonte M;
Lancet Glob Health; 2023 Mar; 11(3):e350-e360. PubMed ID: 36796982
[TBL] [Abstract][Full Text] [Related]
14. [Health technology assessment report: HPV DNA based primary screening for cervical cancer precursors].
Ronco G; Biggeri A; Confortini M; Naldoni C; Segnan N; Sideri M; Zappa M; Zorzi M; Calvia M; Accetta G; Giordano L; Cogo C; Carozzi F; Gillio Tos A; Arbyn M; Mejier CJ; Snijders PJ; Cuzick J; Giorgi Rossi P
Epidemiol Prev; 2012; 36(3-4 Suppl 1):e1-72. PubMed ID: 22828243
[TBL] [Abstract][Full Text] [Related]
15. Detection rates of precancerous and cancerous cervical lesions within one screening round of primary human papillomavirus DNA testing: prospective randomised trial in Finland.
Leinonen MK; Nieminen P; Lönnberg S; Malila N; Hakama M; Pokhrel A; Laurila P; Tarkkanen J; Anttila A
BMJ; 2012 Nov; 345():e7789. PubMed ID: 23197596
[TBL] [Abstract][Full Text] [Related]
16. Protocol for the study of cervical cancer screening technologies in HIV-infected women living in Rwanda.
Murenzi G; Dusingize JC; Rurangwa T; Sinayobye JD; Munyaneza A; Murangwa A; Zawadi T; Hebert T; Mugenzi P; Adedimeji A; Mutesa L; Anastos K; Castle PE
BMJ Open; 2018 Aug; 8(8):e020432. PubMed ID: 30082342
[TBL] [Abstract][Full Text] [Related]
17. Concurrent HPV DNA testing and a visual inspection method for cervical precancer screening: A practical approach from Battor, Ghana.
Effah K; Tekpor E; Wormenor CM; Amuah JE; Essel NO; Atuguba BH; Klutsey GB; Sesenu E; Tay G; Tibu F; Kemawor S; Gedzah I; Morkli EAC; Danyo S; Akakpo PK
PLOS Glob Public Health; 2023; 3(4):e0001830. PubMed ID: 37079498
[TBL] [Abstract][Full Text] [Related]
18. [A study of cervical cancer screening algorithms].
Zhao FH; Zhang WH; Pan QJ; Zhang X; Chen W; Liu B; Ma JF; Hu SY; Qiao YL
Zhonghua Zhong Liu Za Zhi; 2010 Jun; 32(6):420-4. PubMed ID: 20819481
[TBL] [Abstract][Full Text] [Related]
19. Cervical precancer screening with HPV DNA testing and mobile colposcopy in women with sickle cell disease in Accra, Ghana.
Dei-Adomakoh Y; Effah K; Tekpor E; Crabbe S; Amuah JE; Wormenor CM; Tay G; Asare EV; Kemawor S; Danyo S; Morkli EAC; Tibu F; Essel NO; Akakpo PK
Ecancermedicalscience; 2023; 17():1571. PubMed ID: 37533951
[TBL] [Abstract][Full Text] [Related]
20. Mobile colposcopy by trained nurses in a cervical cancer screening programme at Battor, Ghana.
Effah K; Wormenor MC; Tekpor E; Amuah JE; Atuguba HB; Mensah ENO; Badzi ES; Danyo S; Agyiri D; Klutsey GB; Akakpo PK
Ghana Med J; 2022 Sep; 56(3):141-151. PubMed ID: 37448995
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
